Rare diseases
Investigational molecules
Locations
Back to Italy1 221 clinical trials in Naples, Italy across 6 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study on Sibeprenlimab for Patients with IgA Nephropathy
ItalyStudy on Botensilimab and Balstilimab for Patients with Advanced Melanoma Resistant to Previous Treatments
ItalyStudy Comparing Pembrolizumab and Brentuximab Vedotin for Patients with Relapsed or Refractory Hodgkin Lymphoma
ItalyStudy on Ertugliflozin for Children and Teens with Type 2 Diabetes
ItalyStudy of Linperlisib for Patients with Relapsed or Refractory Peripheral T/NK Cell or Cutaneous T Cell Lymphoma
ItalyStudy on the Safety and Effectiveness of Pembrolizumab for Patients with Kidney Cancer After Surgery
ItalyStudy of Pembrolizumab as Additional Treatment for Patients with High-Risk Locally Advanced Cutaneous Squamous Cell Carcinoma After Surgery and Radiation
ItalyStudy of Pembrolizumab and Enzalutamide for Patients with Metastatic Castration-Resistant Prostate Cancer
ItalyStudy for Patients with Advanced Malignancies: Continued Treatment with Parsaclisib Alone or with Itacitinib, Ruxolitinib, Ibrutinib, or Tafasitamab
ItalyStudy of Pembrolizumab for Patients with Advanced Solid Tumors
ItalyStudy on MK-7684A and Docetaxel for Treating Metastatic Non-Small Cell Lung Cancer in Patients After Platinum Chemotherapy and Immunotherapy
ItalyStudy of Pembrolizumab and Chemotherapy for Patients with Triple Negative Breast Cancer
ItalyThe busiest research cities in the country
What the registry says about research in the country
Research focusing on pulmonary conditions including innovative treatments for idiopathic pulmonary fibrosis and COPD. Studies evaluate new medications like tezepelumab and investigate respiratory syncytial virus vaccines for older adults.
Clinical trials aim to improve lung function and reduce disease progression in patients with chronic respiratory conditions.
Comprehensive studies targeting various cancer types, with emphasis on targeted therapies and immunological approaches. Investigations include treatments for colorectal, gastric, and lung cancers.
Novel therapeutic combinations and precision medicine approaches are being evaluated for improved patient outcomes.
Studies addressing kidney disease, cardiovascular conditions, and neurological disorders. Innovative treatments for Parkinson's disease and end-stage kidney disease are under investigation.
Research focuses on developing safer and more effective treatments for chronic conditions affecting quality of life.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
